03/04/2021    

PODIATRIC PRODUCTS AND SERVICES IN THE NEWS

FDA Approves Accufix Surgical's Accu-Joint Hemi Implant

 

Accufix Surgical gained approval from the U.S. Food and Drug Administration (FDA) to distribute its Accu-Joint system, a new approach for full restoration of MTP function and motion with no hard bone resecting or weakening. The non-weight bearing implant lets surgical podiatrists choose joint preservation over joint fusion for their patients. 

 

Dr. Glenn Vitale

 

“As a practicing podiatrist for 36 years, I have been dissatisfied with joint replacement implant options for my patients,” Glenn C. Vitale, DPM, inventor of the Accu-Joint told the press. “I have surgically removed many failed implants and have chosen not to use any of the joint implants that are currently on the market today. We finally have the opportunity to choose true anatomical joint preservation over joint fusion.”

 

Source: Sam Brusco, odtmag.com [3/2/21]